Uxua Mancheño

921 total citations
19 papers, 623 citations indexed

About

Uxua Mancheño is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Uxua Mancheño has authored 19 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Oncology and 6 papers in Genetics. Recurrent topics in Uxua Mancheño's work include CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (7 papers). Uxua Mancheño is often cited by papers focused on CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (7 papers). Uxua Mancheño collaborates with scholars based in Spain, France and Switzerland. Uxua Mancheño's co-authors include Sandra Hervás‐Stubbs, Jesús Prìeto, Ignacio Melero, José Ignacio Riezu‐Boj, Juan José Lasarte, Itsaso Mauleón, Diego Alignani, Rubén Hernández-Alcoceba, Gloria González‐Aseguinolaza and Noëlia Casares and has published in prestigious journals such as The Journal of Immunology, Hepatology and Cancer Research.

In The Last Decade

Uxua Mancheño

19 papers receiving 613 citations

Peers

Uxua Mancheño
Arnold Kloos Germany
Amanda N. Henning United States
Adel Samson United Kingdom
Renee Wu United States
Katarzyna Karwacz United Kingdom
Arnold Kloos Germany
Uxua Mancheño
Citations per year, relative to Uxua Mancheño Uxua Mancheño (= 1×) peers Arnold Kloos

Countries citing papers authored by Uxua Mancheño

Since Specialization
Citations

This map shows the geographic impact of Uxua Mancheño's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uxua Mancheño with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uxua Mancheño more than expected).

Fields of papers citing papers by Uxua Mancheño

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uxua Mancheño. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uxua Mancheño. The network helps show where Uxua Mancheño may publish in the future.

Co-authorship network of co-authors of Uxua Mancheño

This figure shows the co-authorship network connecting the top 25 collaborators of Uxua Mancheño. A scholar is included among the top collaborators of Uxua Mancheño based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uxua Mancheño. Uxua Mancheño is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mancheño, Uxua, Javier Glez‐Vaz, Ibón Tamayo, et al.. (2024). Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting glypican 3 effectively control human hepatocellular carcinoma in mice. Hepatology. 82(2). 326–343. 2 indexed citations
2.
Casares, Noëlia, Uxua Mancheño, Eva Santamaría, et al.. (2022). FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma. Molecular Therapy. 31(1). 48–65. 10 indexed citations
3.
Salas‐Benito, Diego, Ibón Tamayo, Uxua Mancheño, et al.. (2021). The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes. British Journal of Cancer. 124(6). 1138–1149. 15 indexed citations
4.
Mancheño, Uxua, Javier Glez‐Vaz, Noëlia Casares, et al.. (2021). Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants. Journal for ImmunoTherapy of Cancer. 9(11). e003351–e003351. 39 indexed citations
5.
Buñuales, María, Manuela González-Aparicio, Sandra Hervás‐Stubbs, et al.. (2021). Adenovirus-Mediated Inducible Expression of a PD-L1 Blocking Antibody in Combination with Macrophage Depletion Improves Survival in a Mouse Model of Peritoneal Carcinomatosis. International Journal of Molecular Sciences. 22(8). 4176–4176. 8 indexed citations
6.
Tamayo, Ibón, Uxua Mancheño, Juan José Lasarte, et al.. (2020). Identification of neoantigen-reactive T cells in hepatocellular carcinoma: implication in adoptive T cell therapy. Journal of Hepatology. 73. S39–S40. 6 indexed citations
7.
Martišová, Eva, Erkuden Casales, María Buñuales, et al.. (2019). Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses. Molecular Therapy. 27(11). 1892–1905. 35 indexed citations
8.
Santamaría, Eva, Eduardo Larequi, Uxua Mancheño, et al.. (2019). Cardiotrophin‐1 is an anti‐inflammatory cytokine and promotes IL‐4–induced M2 macrophage polarization. The FASEB Journal. 33(6). 7578–7587. 11 indexed citations
9.
Salas‐Benito, Diego, Teresa Lozano, Noëlia Casares, et al.. (2017). Expansion of Tumor-Infiltrating CD8+ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy. Cancer Research. 77(13). 3672–3684. 107 indexed citations
10.
Unzu, Carmen, Ignacio Melero, Sandra Hervás‐Stubbs, et al.. (2015). Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression. Gene Therapy. 22(11). 856–865. 13 indexed citations
11.
Hervás‐Stubbs, Sandra, Mario Martínez Soldevilla, Helena Villanueva, et al.. (2015). Identification of TIM3 2′-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy. Oncotarget. 7(4). 4522–4530. 41 indexed citations
12.
Melero, Ignacio, José I. Quetglas, Juan Dubrot, et al.. (2014). Strict Requirement for Vector-Induced Type I Interferon in Efficacious Antitumor Responses to Virally Encoded IL12. Cancer Research. 75(3). 497–507. 35 indexed citations
13.
Hervás‐Stubbs, Sandra, José Ignacio Riezu‐Boj, Uxua Mancheño, et al.. (2014). Conventional but Not Plasmacytoid Dendritic Cells Foster the Systemic Virus–Induced Type I IFN Response Needed for Efficient CD8 T Cell Priming. The Journal of Immunology. 193(3). 1151–1161. 22 indexed citations
14.
Alzuguren, Pilar, Sandra Hervás‐Stubbs, Gloria González‐Aseguinolaza, et al.. (2014). Transient depletion of specific immune cell populations to improve adenovirus‐mediated transgene expression in the liver. Liver International. 35(4). 1274–1289. 13 indexed citations
15.
Unzu, Carmen, Sandra Hervás‐Stubbs, Ana Sampedro, et al.. (2012). Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates. Journal of Translational Medicine. 10(1). 122–122. 56 indexed citations
16.
Hervás‐Stubbs, Sandra, Uxua Mancheño, José Ignacio Riezu‐Boj, et al.. (2012). CD8 T Cell Priming in the Presence of IFN-α Renders CTLs with Improved Responsiveness to Homeostatic Cytokines and Recall Antigens: Important Traits for Adoptive T Cell Therapy. The Journal of Immunology. 189(7). 3299–3310. 36 indexed citations
17.
Fontanellas, Antonio, Sandra Hervás‐Stubbs, Itsaso Mauleón, et al.. (2010). Intensive Pharmacological Immunosuppression Allows for Repetitive Liver Gene Transfer With Recombinant Adenovirus in Nonhuman Primates. Molecular Therapy. 18(4). 754–765. 24 indexed citations
18.
González-Aparicio, Manuela, Pilar Alzuguren, Itsaso Mauleón, et al.. (2010). Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice. Gut. 60(3). 341–349. 88 indexed citations
19.
Hervás‐Stubbs, Sandra, José Ignacio Riezu‐Boj, Iranzu González, et al.. (2010). Effects of IFN‐α as a signal‐3 cytokine on human naïve and antigen‐experienced CD8+ T cells. European Journal of Immunology. 40(12). 3389–3402. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026